Global Pharmaceutical Solid Dosage Contract Manufacturing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Pharmaceutical Solid Dosage Contract Manufacturing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.

Market Overview:

The latest research study on the global Pharmaceutical Solid Dosage Contract Manufacturing market finds that the global Pharmaceutical Solid Dosage Contract Manufacturing market reached a value of USD 85260.0 million in 2022. It’s expected that the market will achieve USD 115030.0 million by 2028, exhibiting a CAGR of 5.12% during the forecast period.

Segmentation Overview:

As for product types, the Tablets segment held the largest market share in 2022.

Key Companies in the global Pharmaceutical Solid Dosage Contract Manufacturing market covered in Chapter 3:

Pillar5 Pharma
Abbott Laboratories
Mikart
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Covance
Emergent BioSolutions
Lyophilization Technology
Haupt Pharma
Cytovance Biologics
Halo Pharmaceutical
BioPharma Solutions
DPT Laboratories
Althea Technologies
Associates of Cape Cod
Fresenius Kabi
Alkermes

In Chapter 4 and Chapter 14.2, on the basis of types, the Pharmaceutical Solid Dosage Contract Manufacturing market from 2018 to 2029 is primarily split into:

Tablets
Capsule
Lozenge
Powder
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Pharmaceutical Solid Dosage Contract Manufacturing market from 2018 to 2029 covers:

Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)